Assessment of the hemodynamic effects of lidocaine administered IV in isoflurane-anesthetized cats

American Journal of Veterinary Research

Volumn 66, Issue 4, 2005, Pages 661-668

  Pypendop, Bruno H ^a   Ilkiw, Jan E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; DEETHYLLIDOCAINE; HEMOGLOBIN; ISOFLURANE; LACTIC ACID; LIDOCAINE; OXYGEN; PLASMA PROTEIN;

ANIMAL EXPERIMENT; ARTERIAL OXYGEN TENSION; ARTICLE; BICARBONATE BLOOD LEVEL; BLOOD GAS PARAMETERS; CARDIOVASCULAR PARAMETERS; CAT; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG BLOOD LEVEL; DRUG EFFECT; GENERAL ANESTHESIA; HEART INDEX; HEART RATE; HEART RIGHT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART WORK; HEMATOCRIT; HEMODYNAMIC PARAMETERS; HEMOGLOBIN DETERMINATION; LACTATE BLOOD LEVEL; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MEAN ARTERIAL PRESSURE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NOCICEPTIVE STIMULATION; NONHUMAN; OXYGEN BLOOD LEVEL; OXYGEN TRANSPORT; PROTEIN BLOOD LEVEL; STEADY STATE; VENOUS OXYGEN TENSION;

ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; ANIMALS; BLOOD GAS ANALYSIS; BLOOD PRESSURE; CATS; DRUG INTERACTIONS; HEART RATE; HEMODYNAMIC PROCESSES; ISOFLURANE; LIDOCAINE; PAIN;

ANIMALIA; FELIS CATUS;

EID: 17544375121     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2005.66.661     Document Type: Article

References (49)

1. Pypendop BH, Ilkiw JE. Hemodynamic effects of sevoflurane in cats. Am J Vet Res 2004;65:20-25.
2. Mutoh T, Nishimura R, Kim HY, et al. Cardiopulmonary effects of sevoflurane, compared with halothane, enflurane, and isoflurane, in dogs. Am J Vet Res 1997;58:885-890.
3. Aida H, Mizuno Y, Hobo S, et al. Cardiovascular and pulmonary effects of sevoflurane anesthesia in horses. Vet Surg 1996;25:164-170.
4. Glass PS, Shafer SL, Reves JG. Intravenous drug delivery systems. In: Miller RD, ed. Anesthesia. 5th ed. Philadelphia: Churchill Livingstone Inc, 2000;377-411.
5. Erhardt W, Haberstroh J, Schindele M, et al. The principle of "balanced anesthesia" in high risk canine patients. Tierarztl Prax 1988;16:179-185.
6. Bailey PL, Egan TE, Stanley TH. Intravenous opioids anesthetics In: Miller RD, ed. Anesthesia. 5th ed. Philadelphia: Churchill Livingstone Inc, 2000;273-376.
7. Hall RI, Murphy MR, Hug CC Jr. The enflurane sparing effect of sufentanil in dogs. Anesthesiology 1987;67:518-525.
8. Murphy MR, Hug CC Jr. The anesthetic potency of fentanyl in terms of its reduction of enflurane MAC. Anesthesiology 1982;57:485-488.
9. Pascoe PJ. Opioid analgesics. Vet Clin North Am Small Anim Pract 2000;30:757-772.
10. Ilkiw JE, Pascoe PJ, Fisher LD. Effect of alfentanil on the minimum alveolar concentration of isoflurane in cats. Am J Vet Res 1997;58:1274-1279.
11. Pascoe PJ, Ilkiw JE, Fisher LD. Cardiovascular effects of equipotent isoflurane and alfentanil/isoflurane minimum alveolar concentration multiple in cats. Am J Vet Res 1997;58:1267-1273.
12. Pypendop BH, Ilkiw JE. The effects of intravenous lidocaine administration on the minimum alveolar concentration of isoflurane in cats. Anesth Analg 2005;100:97-101.
13. Thomasy SM, Pypendop BH, Ilkiw JE, et al. Pharmacokinetics of intravenous lidocaine and its active metabolite, monoethylglycinexylidide, in awake and isoflurane-anesthetized cats. Am J Vet Res 2005;66:in press.
14. Stoelting RK. Pharmacology and physiology in anesthetic practice. 3rd ed. Philadelphia: Lippincott-Raven, 1999.
15. Lumb AB. Nun's applied respiratory physiology. 5th ed. Oxford, England: Butterworth-Heinemann, 2000.
16. Darovic GH. Hemodynamic monitoring: invasive and noninvasive clinical application. 2nd ed. Philadelphia: WB Saunders Co, 1995.
17. Turner DM, Kassell NF, Sasaki T, et al. Time-dependent changes in cerebral and cardiovascular parameters in isoflurane-nitrous oxide-anesthetized dogs. Neurosurgery 1984;14:135-141.
18. DiBartola SP. Introduction to fluid therapy In: DiBartola SP, ed. Fluid therapy in small animal practice. 2nd ed. Philadelphia: WB Saunders Co, 2000;265-280.
19. Blair MR. Cardiovascular pharmacology of local anaesthetics. Br J Anaesth 1975;47(suppl):247-252.
20. de Jong RH, Ronfeld RA, DeRosa RA. Cardiovascular effects of convulsant and supraconvulsant doses of amide local anesthetics. Anesth Analg 1982;61:3-9.
21. Klein SW, Sutherland RI, Morch JE. Hemodynamic effects of intravenous lidocaine in man. Can Med Assoc J 1968;99:472-475.
22. Nunes de Moraes A, Dyson DH, O'Grady MR, et al. Plasma concentrations and cardiovascular influence of lidocaine infusions during isoflurane anesthesia in healthy dogs and dogs with subaortic stenosis. Vet Surg 1998;27:486-497.
23. Beltrame J, Aylward PE, McRitchie RJ, et al. Comparative haemodynamic effects of lidocaine, mexiletine, and disopyramide. J Cardiovasc Pharmacol 1984;6:483-490.
24. McWhirter WR, Frederickson EL, Steinhaus JE. Interactions of lidocaine with general anesthetics. South Med J 1972;65:796-800.
25. Kapur PA, Grogan DL, Fournier DJ. Cardiovascular interactions of lidocaine with verapamil or diltiazem in the dog. Anesthesiology 1988;68:79-85.
26. Rutten AJ, Nancarrow C, Mather LE, et al. Hemodynamic and central nervous system effects of intravenous bolus doses of lidocaine, bupivacaine, and ropivacaine in sheep. Anesth Analg 1989;69:291-299.
27. Johns RA, DiFazio CA, Longnecker DE. Lidocaine constricts or dilates rat arterioles in a dose-dependent manner. Anesthesiology 1985;62:141-144.
28. Yukioka H, Tatekawa S, Nishimura K, et al. Influence of alpha- and beta-adrenergic blockade on systemic and pulmonary hemodynamics during intravenous administration of local anesthetics. Acta Anaesthesiol Scand 1984;28:339-347.
29. Hodgson DS, Dunlop CI, Chapman PL, et al. Cardiopulmonary effects of anesthesia induced and maintained with isoflurane in cats. Am J Vet Res 1998;59:182-185.
30. Berne RM, Levy MN. Control of cardiac output: coupling of heart and blood vessels. In: Berne RM, Levy MN, eds. Cardiovascular physiology. 7th ed. St Louis: Mosby Inc, 1997;195-222.
31. Roizen MF, Horrigan RW, Frazer BM. Anesthetic doses blocking adrenergic (stress) and cardiovascular responses to incision - MAC BAR. Anesthesiology 1981;54:390-398.
32. Ackerman WE III, Colclough GW, Juneja MM, et al. The management of oral mexiletine and intravenous lidocaine to treat chronic painful symmetrical distal diabetic neuropathy. J Ky Med Assoc 1991;89:500-501.
33. Butterworth J, Cole L, Marlow G. Inhibition of brain cell excitability by lidocaine, QX314, and tetrodotoxin: a mechanism for analgesia from infused local anesthetics? Acta Anaesthesiol Scand 1993;37:516-523.
34. Ferrante FM, Paggioli J, Cherukuri S, et al. The analgesic response to intravenous lidocaine in the treatment of neuropathic pain. Anesth Analg 1996;82:91-97.
35. Jonsson A, Cassuto J, Hanson B. Inhibition of burn pain by intravenous lignocaine infusion. Lancet 1991;338:151-152.
36. Ness TJ. Intravenous lidocaine inhibits visceral nociceptive reflexes and spinal neurons in the rat. Anesthesiology 2000; 92:1685-1691.
37. Tanelian DL, MacIver MB. Analgesic concentrations of lidocaine suppress tonic A-delta and C fiber discharges produced by acute injury. Anesthesiology 1991;74:934-936.
38. Narang PK, Crouthamel WG, Carliner NH, et al. Lidocaine and its active metabolites. Clin Pharmacol Ther 1978;24:654-662.
39. Hanna IH, Roberts ES, Hollenberg PF. Molecular basis for the differences in lidocaine binding and regioselectivity of oxidation by cytochromes P450 2B1 and 2B2. Biochemistry 1998;37:311-318.
40. Keenaghan JB, Boyes RN. The tissue distribution, metabolism and excretion of lidocaine in rats, guinea pigs, dogs and man. J Pharmacol Exp Ther 1972;180:454-463.
41. Burney RG, DiFazio CA, Peach MJ, et al. Anti-arrhythmic effects of lidocaine metabolites. Am Heart J 1974;88:765-769.
42. Tilley LP, Weitz J. Pharmacologic and other forms of medical therapy in feline cardiac disease. Vet Clin North Am 1977;7:415-428.
43. Lanier WL, Sharbrough FW, Michenfelder JD. Effects of atracurium, vecuronium or pancuronium pretreatment on lignocaine seizure thresholds in cats. Br J Anaesth 1988;60:74-80.
44. Seo N, Oshima E, Stevens J, et al. The tetraphasic action of lidocaine on CNS electrical activity and behavior in cats. Anesthesiology 1982;57:451-457.
45. Chadwick HS. Toxicity and resuscitation in lidocaine- or bupivacaine-infused cats. Anesthesiology 1985;63:385-390.
46. Englesson S. The influence of acid-base changes on central nervous system toxicity of local anaesthetic agents. I. An experimental study in cats. Acta Anaesthesiol Scand 1974;18:79-87.
47. Englesson S, Grevsten S. The influence of acid-base changes on central nervous system toxicity of local anaesthetic agents. II. Acta Anaesthesiol Scand 1974;18:88-103.
48. Englesson S, Matousek M. Central nervous system effects of local anaesthetic agents. Br J Anaesth 1975;47(suppl):241-246.
49. Heavner JE, Amory DW. Lidocaine and pentylenetetrazol seizure thresholds in cats are not reduced after enflurane anesthesia. Anesthesiology 1981;54:403-408.